Category: natural substances and extractives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Appearance: | yellow to brown powder (est) |
Assay: | 95.00 to 100.00 %
|
Food Chemicals Codex Listed: | No |
Boiling Point: | 374.00 to 375.00 °C. @ 760.00 mm Hg
|
Vapor Pressure: | 0.000001 mmHg @ 25.00 °C. (est) |
Flash Point: | 525.00 °F. TCC ( 273.89 °C. )
|
logP (o/w): | 5.188 (est) |
Shelf Life: | 12.00 month(s) or longer if stored properly. |
Storage: | refrigerate in tightly sealed containers. |
Soluble in: |
| alcohol | | water, slightly | | water, 3.284 mg/L @ 25 °C (est) |
Insoluble in: |
| water |
Organoleptic Properties:
|
Odor and/or flavor descriptions from others (if found). |
|
|
Cosmetic Information:
Suppliers:
Safety Information:
Preferred SDS: View |
European information : |
Most important hazard(s): | None - None found. |
S 02 - Keep out of the reach of children. S 22 - Do not breath dust. S 24/25 - Avoid contact with skin and eyes.
|
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
Not determined
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | natural substances and extractives |
Recommendation for valerenic acid usage levels up to: | | not for fragrance use.
|
|
Recommendation for valerenic acid flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
| (E)-3-[(4S,7R,7aR)-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid |
NIST Chemistry WebBook: | Search Inchi |
Pubchem (cid): | 6440940 |
Pubchem (sid): | 135115560 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
(2E)-3-[(4S,7R,7aR)-3,7- | dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylacrylic acid | (2E)-3-[(4S,7R,7aR)-3,7- | dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid | (E)-3-[(4S,7R,7aR)-3,7- | dimethyl-2,4,5,6,7,7a-hexahydro-1H-inden-4-yl]-2-methylprop-2-enoic acid | (2E)-3-[(4S,7R,7aR)-2,4,5,6,7,7a- | hexadydro-3,7-dimethyl-1H-inden-4-yl]-2-methyl-2-propenoic acid | (4S-(4alpha(E),7beta,7aalpha))-3-(2,4,5,6,7,7a- | hexahydro-3,7-dimethyl-1H-inden-4-yl)-2-methyl-2-propenoic acid | 2- | propenoic acid, 3-[(4S,7R,7aR)-2,4,5,6,7,7a-hexahydro-3,7-dimethyl-1H-inden-4-yl]-2-methyl-, (2E)- | | valerenicacid | | valerinic acid |
Articles:
PubMed: | Esters of valerenic acid as potential prodrugs. |
PubMed: | Revised structures of nardal and nardin: identity with valerenal and valerenic acid. |
PubMed: | Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation. |
PubMed: | Antioxidant effect and study of bioactive components of Valeriana sisymbriifolia and Nardostachys jatamansii in comparison to Valeriana officinalis. |
PubMed: | Functional identification of valerena-1,10-diene synthase, a terpene synthase catalyzing a unique chemical cascade in the biosynthesis of biologically active sesquiterpenes in Valeriana officinalis. |
PubMed: | Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity. |
PubMed: | Anxiolytic properties of Valeriana officinalis in the zebrafish: a possible role for metabotropic glutamate receptors. |
PubMed: | Enzymatic synthesis of valerena-4,7(11)-diene by a unique sesquiterpene synthase from the valerian plant (Valeriana officinalis). |
PubMed: | Pharmacokinetics of valerenic acid in rats after intravenous and oral administrations. |
PubMed: | Efficient and scalable one-pot synthesis of 2,4-dienols from cycloalkenones: optimized total synthesis of valerenic acid. |
PubMed: | Three phases hollow fiber LPME combined with HPLC-UV for extraction, preconcentration and determination of valerenic acid in Valeriana officinalis. |
PubMed: | Selective Interactions of Valeriana officinalis Extracts and Valerenic Acid with [H]Glutamate Binding to Rat Synaptic Membranes. |
PubMed: | Telemetry as a tool to measure sedative effects of a valerian root extract and its single constituents in mice. |
PubMed: | Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. |
PubMed: | Concise synthesis of Valerena-4,7(11)-diene, a highly active sedative, from valerenic acid. |
PubMed: | Valerenic acid derivatives as novel subunit-selective GABAA receptor ligands - in vitro and in vivo characterization. |
PubMed: | Highly potent modulation of GABA(A) receptors by valerenic acid derivatives. |
PubMed: | Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. |
PubMed: | Root colonization by symbiotic arbuscular mycorrhizal fungi increases sesquiterpenic acid concentrations in Valeriana officinalis L. |
PubMed: | Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle. |
PubMed: | Total synthesis of valerenic acid, a potent GABAA receptor modulator. |
PubMed: | Hepatic metabolism and biliary excretion of valerenic acid in isolated perfused rat livers: role of Mrp2 (Abcc2). |
PubMed: | Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. |
PubMed: | GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. |
PubMed: | HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes. |
PubMed: | [Studies on chemical constituents of Valeriana officinalis]. |
PubMed: | Essential oil composition of Valeriana officinalis L. roots cultivated in Iran. Comparative analysis between supercritical CO2 extraction and hydrodistillation. |
PubMed: | Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. |
PubMed: | [GC-MS analysis of volatile constituents from five different kinds of Chinese eaglewood]. |
PubMed: | Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. |
PubMed: | Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro. |
PubMed: | NF-kappaB modulators from Valeriana officinalis. |
PubMed: | Commercial valerian interactions with [3H]Flunitrazepam and [3H]MK-801 binding to rat synaptic membranes. |
PubMed: | Chemical fingerprinting of valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection. |
PubMed: | Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. |
PubMed: | Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. |
PubMed: | Extraction of valerenic acids from valerian (Valeriana officinalis L.) rhizomes. |
PubMed: | In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. |
PubMed: | Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. |
PubMed: | Stability control of valerian ground material and extracts: a new HPLC-method for the routine quantification of valerenic acids and lignans. |
PubMed: | Essential oil of Valeriana officinalis L. cultivars and their antimicrobial activity as influenced by harvesting time under commercial organic cultivation. |
PubMed: | Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. |
PubMed: | The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. |
PubMed: | In vitro release of valerenic and hydroxyvalerenic acids from valerian tablets. |
PubMed: | (-)-3 beta,4 beta-epoxyvalerenic acid from Valeriana officinalis. |
PubMed: | Valepotriates and valerenic acids in commercial preparations of valerian available in Australia. |
PubMed: | Analysis of sesquiterpenes in Valeriana officinalis by capillary electrophoresis. |
PubMed: | Polysomnographic evaluation of the hypnotic effect of Valeriana edulis standardized extract in patients suffering from insomnia. |
PubMed: | Valerenic acid derivatives and valepotriates among individuals, varieties and species of Valeriana. |
PubMed: | The scientific basis for the reputed activity of Valerian. |
PubMed: | Cytotoxic potential of valerian constituents and valerian tinctures. |
PubMed: | Seasonal variation of the essential oil, valerenic acid and derivatives, and velopotriates in Valeriana officinalis roots and rhizomes, and the selection of plants suitable for phytomedicines. |
PubMed: | In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. |
PubMed: | Central nervous depressant activity of valerenic Acid in the mouse. |
PubMed: | Central nervous depressant activity of valerenic acid in the mouse. |
PubMed: | [Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives]. |
|